Mark E. Smolkin

Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma

Gulsun Erdag, Jochen T. Schaefer, Mark E. Smolkin et al. · Cancer Research · 2012 · 614 citations · Full text

Medicine, Oncology, Pathology +17

Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial

Craig L. Slingluff, Gina R. Petroni, Walter C. Olson et al. · Clinical Cancer Research · 2009 · 170 citations · Full text

Medicine, Immunology, Oncology +17

Immunologic and Clinical Outcomes of a Randomized Phase II Trial of Two Multipeptide Vaccines for Melanoma in the Adjuvant Setting

Craig L. Slingluff, Gina R. Petroni, Kimberly A. Chianese‐Bullock et al. · Clinical Cancer Research · 2007 · 163 citations · Full text

Medicine, Immunology, Oncology +17

Prognostic value of albumin in patients with head and neck cancer

Deepa Danan, David C. Shonka, Yamil Selman et al. · The Laryngoscope · 2016 · 131 citations

Medicine, Oncology, Surgery +13

PD-L1, PD-L2 and PD-1 expression in metastatic melanoma: Correlation with tumor-infiltrating immune cells and clinical outcome

Joseph M. Obeid, Gulsun Erdag, Mark E. Smolkin et al. · OncoImmunology · 2016 · 131 citations · Full text

Life Sciences, Immunology, Oncology +17